Recent Finacing
Recent Raise
Stingray Bio is a University of Sussex spin-out developing small-molecule inhibitors of the LMTK3 kinase pathway for cancer, with preclinical validation and programs advancing toward clinical application.
Focus Areas
Recent Investors
Funding round
Investor